| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $4.85 | - | - |
| Q1'26 | $6.60 | $7.23 | +9.5% |
| Q4'25 | $2.12 | $2.11 | -0.6% |
| Q3'25 | $2.81 | $2.92 | +4.0% |
| Q2'25 | $4.45 | $4.08 | -8.2% |
| Q1'25 | $7.29 | $7.20 | -1.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $110.8B | - | - |
| Q1'26 | $109.7B | $111.7B | +1.9% |
| Q4'25 | $115.0B | $113.2B | -1.5% |
| Q3'25 | - | $113.2B | - |
| Q2'25 | - | $111.6B | - |
| Q1'25 | - | $109.6B | - |
Market Data
UNH is currently trading at $424.50, giving UnitedHealth Group Incorporated a market cap of 385.62B and a P/E ratio of 32.0. Today's range spans $423.65–$433.99, with shares opening at $431.67 and moving down $0.08 (0.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 68/100.
Over the past year UNH has traded between $234.60 and $434.30 - the current price is +80.9% off the 52-week low and -2.3% from the high. 35 analysts cover the stock with a Buy consensus and a mean 12-month target of $420.46 (range $287.00–$492.00), implying downside of -1.0%.
Growth-oriented Healthcare investors looking for technical confirmation find it in UNH: BUY signal, 82/100 score, bullish sentiment at 68/100, price $424.50 (near 52-week highs). The current P/E ratio stands at 32.0. The 385.62B market cap is the sweet spot - big enough to absorb institutional sizing, small enough to move materially on conviction. Annual range: $234.60–$434.30.
The combination of a BUY signal (82/100) and bullish news sentiment (68/100) puts UNH on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 385.62B in Healthcare market cap without immediately moving the stock. At $424.50 (near 52-week highs in the $234.60–$434.30 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).